Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study

Analysis (n=87,794) found increased risk of cardiovascular diseases (CVD) associated with glucocorticoid use, even at lower doses (<5 mg), in 6 immune-mediated diseases. Incident CVD occurred in 13,426 (15.3%; 6,013 atrial fibrillation, 7,727 heart failure and 2,809 acute MI).

PLOS Medicine